A case of an unfavorable outcome of Мycoplasma pneumonia with the formation of fibrotic changes in the lungs in a child
https://doi.org/10.22627/2072-8107-2020-19-4-64-68
Abstract
Community-acquired pneumonia is a polietiologic disease and a significant cause of death worldwide. One of the pathogens of pneumonia is Mycoplasma pneumoniae, which in school-age children occupies the first place in the etiological structure, including the formation of foci of group morbidity. In most cases, mycoplasma infection has a smooth course, but possibly a protracted course with the development of progressive changes in the lungs.
The aim of the work is to describe our own observation of the development of pneumofibrotic changes in a child who has undergone mycoplasma pneumonia.
The article presents a description of a case of mycoplasma bronchopneumonia in a teenager, with prolonged persistence of febrile fever, catarrhal syndrome, the development of a rash in the structure of mycoplasma infection, a pronounced bilateral inflammatory process in the lungs followed by the formation of post-inflammatory changes in the form of pulmonary fibrosis, which were confirmed only by computed tomography and dynamic monitoring of the patient.
Conclusion. The above example showed the need for long-term follow-up of patients with prolonged mycoplasma pneumonia by pulmonologists and the development of targeted rehabilitation.
About the Authors
E. V. Sharipova
Pediatric Research and Clinical Center for Infectious Diseases
Russian Federation
Russian Federation
Elena Sharipova, PhD, senior researcher associate of department of respiratory (drop) infections
Saint-Petersburg
I. V. Babachenko
Pediatric Research and Clinical Center for Infectious Diseases
Russian Federation
Russian Federation
MD, professor, leading researcher, head of department of respiratory (drop) infections
Saint-Petersburg
E. A. Kozyrev
Pediatric Research and Clinical Center for Infectious Diseases
Russian Federation
Russian Federation
postgraduate student of department of respiratory (drop) infections
Saint-Petersburg
N. V. Marchenko
Pediatric Research and Clinical Center for Infectious Diseases
Russian Federation
Russian Federation
PhD, Head of the Department of Radiation Diagnostics
Saint-Petersburg
References
1. О состоянии санитарно-эпидемиологического благополучия населения в Российской Федерации в 2019 году: Государственный доклад. М.: Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека. 2020: 299. [On the state of sanitary and epidemiological well-being of the population in the Russian Federation in 2019: State report. Moscow: Federal Service for Supervision of Consumer Rights Protection and Human Welfare. 2020: 299.(In Russ.)]
2. Chaudhry R., Ghosh A., Chandolia A. Pathogenesis of Mycoplasma pneumoniae: An update. Indian J Med Microbiol. 2016; 34:7- 16. DOI: 10.4103/0255-0857.174112
3. ZabMosenifar: Viral Pneumonia [Internet]. University of California at Los Angeles [Updated: Jan 22, 2020]. Available from: https://emedicine.medscape.com/article/300455-overview
4. Разуваев О.А. Диагностика и профилактика пневмоний микоплазменной этиологии у детей: Автореф. дис. … к.м.н. Воронеж, 2018. [Razuvaev O.A.Diagnostics and prevention of pneumonia of mycoplasma etiology in children: Author's abstract. dis. ... Ph.D. Voronezh, 2018. (In Russ.)]
5. Орлов А.В.,Пашкевич А.А., Гончар Н.В., Борисенко Т.С., Бабаченко И.В., Романюк Ф.П. Бронхоаденит при микоплазменной пневмонии у ребенка: дифференциальная диагностика и лечение. Вестник Северо-Западного государственного медицинского университета им. И.И. Мечникова. 2019; 11(2): 71—78. [Orlov A.V., Pashkevich A.A., Gonchar N.V., Borisenko T.S., Babachenko I.V., Romanyuk F.P. Bronchoadenitissimplex at Mycoplasma pneumonia at the child (Differential diagnostics and treatment). VestnikSevero-Zapadnogogosudarstvennogomeditsinskogouniversitetaim I IMechnikova=Herald of North-Western State Medical University named after I.I. Mechnikov. 2019; 11(2): 71 — 78. (In Russ.) doi.org/10.17816/mechnikov201911271-78]
6. Кошкарина Е.А., Квашнина Д.В., Широкова И.Ю. Клинико-эпидемиологические и иммунологические характеристики микоплазменных пневмоний (аналитический обзор). Журнал МедиАль. 2019; (1):7—18. [Koshkarina E.A., Kvashnina D.V., Shirokova I.Yu. Clinical, epidemiological and immunological characteristics of mycoplasma pneumonia (analytical review). ZhurnalMediAl=MediAl. 2019; (1):7— 18. (In Russ.) doi.org/10.21145/2225-0026-2019-1-7-18]
7. Zhang W., Zhang S., Wang Q., Li Y., Jing H., Hu G., Wu D. Outbreak of macrolide-resistant mycoplasma pneumoniae in a primary school in Beijing, China in 2018. BMC Infect Dis. 2019 Oct 22; 19(1):871. doi.org/10.1186/s12879-019-4473-6
8. ЗайцеваС.В., Застрожина А.К., Муртазаева О.А. Микоплазменная инфекция у детей (обзор литературы). РМЖ. 2017. 5: 327—334. [Zaitseva S.V., Zastrozhina A.K., Murtazaeva O.A. Mycoplasma infection in children (literature review). RMJ. 2017; 5:327—334. (In Russ.)]
9. Montagnani F., Rossetti B., Vannoni A., GraziaCusi M., De Luca A. Laboratory diagnosis of Mycoplasma pneumoniae infections: data analysis from clinical practice. New Microbiologica. 2018; 41(3): 203—207. http://www.newmicrobiologica.org/PUB/allegati_pdf/2018/3/203.pdf.
10. Vallejo J.G. Mycoplasma pneumoniae infection in children [Internet]. Baylor College of Medicine [Updated: Feb 25, 2020]. https://www.uptodate.com/contents/mycoplasma-pneumoniae-infection-in-children/contributors.
11. Kaufman J.M., Cuvelier C.A., Van der Straeten M. Mycoplasma pneumonia with fulminant evolution into diffuse interstitial fibrosis. Thorax. 1980; 35(2):140—144. dx.doi.org/10.1136/thx.35.2.140
12. Tablan O.C., Reyes M.P. Chronic interstitial pulmonary fibrosis following mycoplasma pneumoniae pneumonia. The American Journal of Medicine. 1985; 79(2):268—270. doi.org/10.1016/0002-9343(85)90021-X
13. Kumar S. Mycoplasma pneumoniae: A significant but underrated pathogen in paediatric community-acquired lower respiratory tract infections. Indian J Med Res. 2018; 147(1):23—31. DOI: 10.4103/ijmr.IJMR_1582_16
14. Рубцовенко А.В. Патологическая физиология. М.: МЕДпресс-информ, 2006:608. [Rubtsovenko A.V. Pathological physiology. M.: MEDpress-inform, 2006:608. (In Russ.)]
15. Chaudhry R., Ghosh A., Chandolia A. Pathogenesis of Mycoplasma pneumoniae: An update. Indian J Med Microbiol. 2016 JanMar; 34(1):7—16. doi: 10.4103/0255-0857.174112. PMID: 26776112
16. Youn Y.S., Lee K.Y. Mycoplasma pneumoniae pneumonia in children. Korean J Pediatr. 2012; 55(2):42—47. doi:10.3345/kjp.2012.55.2.42
Review
For citations:
Sharipova E.V., Babachenko I.V., Kozyrev E.A., Marchenko N.V. A case of an unfavorable outcome of Мycoplasma pneumonia with the formation of fibrotic changes in the lungs in a child. CHILDREN INFECTIONS. 2020;19(4):64-68. (In Russ.) https://doi.org/10.22627/2072-8107-2020-19-4-64-68
Views:
1112
Email this article 